Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 384
Aptamer sequence: UGCUCUUAGAAUGGGACUAAGACACGGGAC
Target unique ID: P27958
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_378 G9-Ⅱ Protein POLG_HCV77 6.3 nM 50 mM Tris/HCl (pH 7.8), 30 mM NaCl, 5 mM CaCl2 and 10 mM dithiothreitol 10848986
Structure information of aptamer
Aptamer Sequence: UGCUCUUAGAAUGGGACUAAGACACGGGAC
The optimal secondary structure in dot-bracket notation: ((.((((((.......))))))))......
The centroid secondary structure in dot-bracket notation: .(.((((((.......))))))).......
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_378 Description G9-Ⅱ
Aptamer chemistry RNA Length 30 nt
GC content 50.0% Molecular weight 9,675.82 Da
Molarity of 1 μg/μl solution 103.35 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence UGCUCUUAGAAUGGGACUAAGACACGGGAC
Applications Selected aptamers have potential as anti-HCV compounds
Target information
Type Detail Type Detail
Uniprot ID P27958 Protein name Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Gene name(s) N/A Organism Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Status reviewed in uniprot database Length 3011
Mass 327,146 Activity regulation Inhibited by the antiviral drug hexamethylene amiloride (By similarity)
Involvement in disease N/A Catalytic activity Reaction=Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1
PDB ID(s)
1A1R;1A1V;1CWX;1HEI;1JR6;1N1L;1ONB;1R7C;1R7D;1R7E;1R7F;1R7G;1RGQ;2A4R;2F9V;2HD0;2JXF;2KDR;2N1P;2O8M;2OBO;2OBQ;2OC0;2OC1;2OC7;2OC8;2OIN;2P59;2QV1;2XI2;2XI3;2XNI;3RC4;3RC5;4CL1;4JZN;4JZO;4MWF;4N0Y;4Q0X;4XVJ;4Z0X;5EOC;5ERW;5FGB;5FGC;5JZI;5YXN;5YXU;6BQJ;6BQK;6BZU;6BZV;6BZW;6BZY;6UYD;6WO5;6WOQ;
Function Packages viral RNA to form a viral nucleocapsid, and promotes virion budding (Probable).
Activity data
Interaction ID 384
Target type Protein
Target unique ID P27958
Activity 6.3 nM
Binding Conditions/Buffer

50 mM Tris/HCl (pH 7.8), 30 mM NaCl, 5 mM CaCl2 and 10 mM dithiothreitol

Assay

Binding curves of selected RNA aptamers and DNS3. Data points were obtained by filter binding assay (50 mL reaction) as described in Materials and methods (G9-I, circle; G9-II, cross; and G9-III, square). The concentration of labeled aptamers was 5 nm

PubMed ID 10848986
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_379 RNA UACGACACGAUUGGGACGUGUCUAUGGGAC 56.67%
Apta_1167 RNA GGCGCGAGGAAGGAGGUCUGAGGAGGUCACUGCGCC 55.56%
Apta_633 RNA GGCAUCGGAAAGUGGGUUGAUGUAAGUAACAGGCGAUGCC 55.00%
Apta_560 RNA GGAAGAGAUGGCGACUAAAACGACUUGUCGC 51.61%
Apta_237 RNA UUCAACGCUGUGAAGGGCUUAUACGAGCGGAUUACCC 51.35%
Apta_51 RNA GCCUUAGUAACGUGCUUUGAUGUCGAUUCGACAGGAGGC 51.28%
Apta_206 DNA AGGAAGGGGTCTGAGATCTCGGAAT 50.00%
Apta_319 RNA ACCCUGAUGGUAGACGCCGGGGUG 50.00%
Apta_323 DNA GGCTATAGCACATGGGTAAAACGAC 50.00%
Apta_323 DNA GGCTATAGCACATGGGTAAAACGAC 50.00%
Apta_323 DNA GGCTATAGCACATGGGTAAAACGAC 50.00%
Apta_367 RNA CGAGCGUAGAAUGUCUUCCCACUAGACGUCGUUCGGCCCC 50.00%
Apta_647 RNA GGAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAUCC 50.00%
Apta_647 RNA GGAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAUCC 50.00%
Apta_1292 RNA GGCACGUGUAUUACCCUAGUGGUCGACGUGCC 50.00%
Apta_1121 RNA GACAGCGUGCCUAGAAGUCCAAGCUUAAAUAACCACGCUCGACAAGC 48.94%
Apta_90 RNA ACAACCUAAAUGCGACGUUGGGUCAAAAACGUGAA 48.57%
Apta_93 RNA CUCCGCUAUCUAACGUAUGAUAGAAUGGAUGACUA 48.57%
Apta_713 RNA GGCGGUGCUGGCCGAAAGGCGCUUGGAAACGUC 48.48%
Apta_136 RNA CGUGUCGUCCUGGUACGAUUUGGUAUAUAACCGUGGCUUUUCGACA 47.83%